ReviewVaccines2024

Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas.

Kawaljit Kaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.